CoChat

Octreotide therapy in dumping syndrome: analysis of long‐term results

Open access
DIDDEN, P., PENNING, C., MASCLEE, A. A. M. · 2006 · Alimentary Pharmacology & Therapeutics
Cited by 51

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Summary: Background: Octreotide therapy is effective in controlling severe dumping symptoms during short‐term follow‐up but little is known about long‐term results. Aim: To report on the long‐term results of patients with severe dumping syndrome treated at the Leiden University Medical Center with subcutaneous or depot intramuscular (long‐acting release) octreotide. Methods: Follow‐up of 34 patients with severe dumping syndrome refractory to other therapeutic measures treated between 1987 and 2005 with octreotide subcutaneous/long‐acting release. At regular intervals symptoms, quality of life, weight, faecal fat excretion and gallstone formation were evaluated. Results: All patients had excellent initial relief of symptoms during octreotide subcutaneous therapy. However, during follow‐up 16 patients stopped therapy because of side effects (n = 9) or loss of efficacy (n = 7). Four patients died. Fourteen patients (41%) remain using octreotide (follow‐up 93 ± 15 months), seven are on octreotide subcutaneous and seven on octreotide long‐acting release. Patients with severe dumping (both early and late) do better on subcutaneous than long‐acting release despite the inconvenience of frequent injections. Dumping symptoms are reduced by 50% even in long‐term users. Body weight continues to increase during therapy despite more pronounced steatorrhoea. Conclusion: The long‐term the efficacy of octreotide is much less favourable compared with short‐term treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2006.03124.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 51

Metadata

Authors
DIDDEN, P., PENNING, C., & MASCLEE, A. A. M.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2006-10-16
Volume
24
Issue
9
Pages
1367-1375
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W1964082026
Cited by
51
References
5
FWCI
2.05
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.